Moorthy S. S. Palanki

1.1k total citations
28 papers, 818 citations indexed

About

Moorthy S. S. Palanki is a scholar working on Molecular Biology, Organic Chemistry and Cancer Research. According to data from OpenAlex, Moorthy S. S. Palanki has authored 28 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Organic Chemistry and 10 papers in Cancer Research. Recurrent topics in Moorthy S. S. Palanki's work include Cytokine Signaling Pathways and Interactions (8 papers), NF-κB Signaling Pathways (8 papers) and Chemical Synthesis and Analysis (5 papers). Moorthy S. S. Palanki is often cited by papers focused on Cytokine Signaling Pathways and Interactions (8 papers), NF-κB Signaling Pathways (8 papers) and Chemical Synthesis and Analysis (5 papers). Moorthy S. S. Palanki collaborates with scholars based in United States, Switzerland and Spain. Moorthy S. S. Palanki's co-authors include Lynn J. Ransone, Anthony M. Manning, Mark J. Suto, Paul Erdman, Dale L. Boger, Mark E. Goldman, Robert W. Sullivan, Zuoning Han, Miguel Barbosa and David Boyle and has published in prestigious journals such as Journal of the American Chemical Society, Blood and The Journal of Immunology.

In The Last Decade

Moorthy S. S. Palanki

28 papers receiving 759 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Moorthy S. S. Palanki United States 18 441 297 122 118 110 28 818
Fusako Nishigaki Japan 19 469 1.1× 159 0.5× 141 1.2× 120 1.0× 183 1.7× 41 1.0k
Giang T. Le Australia 14 537 1.2× 249 0.8× 121 1.0× 61 0.5× 108 1.0× 18 825
Sachiko Sakakibara Japan 13 307 0.7× 260 0.9× 136 1.1× 117 1.0× 158 1.4× 20 773
Carol Torcellini United States 10 290 0.7× 231 0.8× 148 1.2× 41 0.3× 103 0.9× 13 801
Stuart B. Rosenblum United States 13 173 0.4× 326 1.1× 179 1.5× 64 0.5× 204 1.9× 23 725
Hisao Fukumoto Japan 17 587 1.3× 119 0.4× 53 0.4× 129 1.1× 432 3.9× 30 1.0k
Matthew Labenski United States 12 405 0.9× 200 0.7× 70 0.6× 37 0.3× 166 1.5× 20 701
Eva‐Laure Matera France 16 355 0.8× 145 0.5× 88 0.7× 80 0.7× 314 2.9× 32 815
Michelle L. Kraus United States 7 466 1.1× 96 0.3× 101 0.8× 129 1.1× 447 4.1× 9 1.1k
Roben G. Gieling United Kingdom 14 482 1.1× 204 0.7× 80 0.7× 109 0.9× 82 0.7× 22 921

Countries citing papers authored by Moorthy S. S. Palanki

Since Specialization
Citations

This map shows the geographic impact of Moorthy S. S. Palanki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moorthy S. S. Palanki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moorthy S. S. Palanki more than expected).

Fields of papers citing papers by Moorthy S. S. Palanki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moorthy S. S. Palanki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moorthy S. S. Palanki. The network helps show where Moorthy S. S. Palanki may publish in the future.

Co-authorship network of co-authors of Moorthy S. S. Palanki

This figure shows the co-authorship network connecting the top 25 collaborators of Moorthy S. S. Palanki. A scholar is included among the top collaborators of Moorthy S. S. Palanki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moorthy S. S. Palanki. Moorthy S. S. Palanki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Jie, Tetsuya Ishino, Gang Chen, et al.. (2013). Development of a Novel Long-Acting Antidiabetic FGF21 Mimetic by Targeted Conjugation to a Scaffold Antibody. Journal of Pharmacology and Experimental Therapeutics. 346(2). 270–280. 102 indexed citations
2.
Palanki, Moorthy S. S., Abhijit Bhat, Ben Bolaños, et al.. (2012). Development of a long acting human growth hormone analog suitable for once a week dosing. Bioorganic & Medicinal Chemistry Letters. 23(2). 402–406. 15 indexed citations
3.
Palanki, Moorthy S. S., Abhijit Bhat, Rodney W. Lappe, et al.. (2012). Development of novel linkers to conjugate pharmacophores to a carrier antibody. Bioorganic & Medicinal Chemistry Letters. 22(13). 4249–4253. 17 indexed citations
4.
Moore‐Carrasco, Rodrigo, Sı́lvia Busquets, Maite Figueras, et al.. (2009). Both AP-1 and NF-kappaB seem to be involved in tumour growth in an experimental rat hepatoma.. PubMed. 29(4). 1315–7. 10 indexed citations
5.
Noronha, Glenn, Jianguo Cao, Elena Dneprovskaia, et al.. (2008). Inhibitors of ABL and the ABL-T315I Mutation. Current Topics in Medicinal Chemistry. 8(10). 905–921. 34 indexed citations
6.
Fujimoto, Hajime, Corina N. D’Alessandro‐Gabazza, Moorthy S. S. Palanki, et al.. (2007). Inhibition of Nuclear Factor-κB in T Cells Suppresses Lung Fibrosis. American Journal of Respiratory and Critical Care Medicine. 176(12). 1251–1260. 21 indexed citations
7.
Palanki, Moorthy S. S., Elena Dneprovskaia, John Doukas, et al.. (2007). Discovery of 3,3‘-(2,4-Diaminopteridine-6,7-diyl)diphenol as an Isozyme-Selective Inhibitor of PI3K for the Treatment of Ischemia Reperfusion Injury Associated with Myocardial Infarction. Journal of Medicinal Chemistry. 50(18). 4279–4294. 40 indexed citations
8.
Cao, Jianguo, Richard Fine, John Hood, et al.. (2007). The design and preliminary structure–activity relationship studies of benzotriazines as potent inhibitors of Abl and Abl-T315I enzymes. Bioorganic & Medicinal Chemistry Letters. 17(21). 5812–5818. 21 indexed citations
9.
Palanki, Moorthy S. S., Paul Erdman, Mark J. Suto, et al.. (2003). The design and synthesis of novel orally active inhibitors of AP-1 and NF-κB mediated transcriptional activation. SAR of In vitro and In vivo studies. Bioorganic & Medicinal Chemistry Letters. 13(22). 4077–4080. 32 indexed citations
10.
Palanki, Moorthy S. S.. (2002). Inhibitors of AP-1 and NF-κB Mediated Transcriptional Activation: Therapeutic Potential in Autoimmune Diseases and Structural Diversity. Current Medicinal Chemistry. 9(2). 219–227. 53 indexed citations
11.
Gerlag, Daniëlle M., Lynn J. Ransone, Paul P. Tak, et al.. (2000). The Effect of a T Cell-Specific NF-κB Inhibitor on In Vitro Cytokine Production and Collagen-Induced Arthritis. The Journal of Immunology. 165(3). 1652–1658. 89 indexed citations
12.
Palanki, Moorthy S. S., Paul Erdman, Anthony M. Manning, et al.. (2000). Novel inhibitors of AP-1 and NF-κB mediated gene expression: structure–activity relationship studies of ethyl 4-[(3-Methyl-2,5-dioxo(3-pyrrolinyl))amino]-2-(trifluoromethyl)pyrimidine-5-carboxylate. Bioorganic & Medicinal Chemistry Letters. 10(15). 1645–1648. 29 indexed citations
13.
Palanki, Moorthy S. S. & Anthony M. Manning. (1999). Interleukin-2 inhibitors in autoimmune disease. Expert Opinion on Therapeutic Patents. 9(1). 27–39. 7 indexed citations
14.
15.
Suto, Mark J., et al.. (1998). Solution-phase parallel synthesis using ion-exchange resins. Tetrahedron. 54(16). 4141–4150. 29 indexed citations
16.
Suto, Mark J., et al.. (1998). ChemInform Abstract: Solution‐Phase Parallel Synthesis Using Ion‐Exchange Resins.. ChemInform. 29(30). 1 indexed citations
17.
Charnock‐Jones, D. Stephen, P A Barstad, John Hachmann, et al.. (1995). Immunospecific Reduction of Antioligonucleotide Antibody-Forming Cells with a Tetrakis-oligonucleotide Conjugate (LJP 394), a Therapeutic Candidate for the Treatment of Lupus Nephritis. Journal of Medicinal Chemistry. 38(12). 2138–2144. 52 indexed citations
18.
19.
Grunewald, Gary L., Moorthy S. S. Palanki, & Fusao Takusagawa. (1991). Structures of two conformationally defined phenylethanolamines: exo-1,4-epoxy-2-formamido-1,2,3,4-tetrahydro-8-trifluoromethylnaphthalene and exo-1,4-epoxy-2-formamido-1,2,3,4-tetrahydro-6-trifluoromethylnaphthalene. Acta Crystallographica Section C Crystal Structure Communications. 47(4). 771–775. 2 indexed citations
20.
Grunewald, Gary L., et al.. (1990). ONE-STEP SYNTHESIS OF TRIFLUOROMETHYL- AND OF METHOXY-SUBSTITUTED BENZYNE PRECURSORS. Organic Preparations and Procedures International. 22(6). 747–753. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fusako Nishigaki Breakdown of academic impact, for papers by Giang T. Le Breakdown of academic impact, for papers by Sachiko Sakakibara Breakdown of academic impact, for papers by Carol Torcellini Breakdown of academic impact, for papers by Stuart B. Rosenblum Breakdown of academic impact, for papers by Hisao Fukumoto Breakdown of academic impact, for papers by Matthew Labenski Breakdown of academic impact, for papers by Eva‐Laure Matera Breakdown of academic impact, for papers by Michelle L. Kraus Breakdown of academic impact, for papers by Roben G. Gieling
Rankless by CCL
2026